Nipro recalls GlucoPro insulin syringes

- Last updated on GMT

Related tags: Syringe, Hypodermic needle

Nipro Medical has recalled all batches of its GlucoPro insulin syringes in the US after discovering that the needles could detach during use.

The voluntary withdrawal covers all GlucoPro syringes with expiration dates before November 2011, but does not include syringes designed for use with Nipro’s Amigo insulin pump.

The firm, which is owned by Japan’s Nipro Corporation, said it has informed the US Food and Drug Administration of the recall and added that it has received no reports of injuries associated with the GlucoPro product.

Nipro is the second syringe maker to be hit by such problems in the last six months behind Qualitest Pharmaceuticals​, which pulled 250m of its Accusure prefilled insulin needles in October.

Related news

Related products

show more

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Related suppliers

Follow us

Products

View more

Webinars